Adherence to pomalidomide in patients with multiple myeloma: A US-based claims study.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e20008
Abstract: e20008Background: Pomalidomide is indicated for use in multiple myeloma (MM) for those who have received at least two prior therapies. Data on real world medication use and factors associated with ... read more here.
Keywords: myeloma based; based claims; pomalidomide patients; multiple myeloma ... See more keywords